[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy

What is the purpose of the study?

To evaluate the safety, tolerability, and how effective Xen1101 is in treating adults with focal epilepsy.

Upstate Institutional Review Board (IRB) Number:

1413240

Study/Protocol ID:

XPF-008-201

Study Phase:

Phase 2

Patient Age Group:

Adults

Principal Investigator:

Shahram Izadyar

What is involved if I participate?

  • How long is the study?
    24 Weeks (5-6 Months)
  • Is transportation provided or reimbursed?
    Yes
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Physical and Neurologic examinations, Blood samples collected, Pregnancy Test, ECG

Where will the study take place?

Clinical Research Unit on the 1st floor of the IHP building.

ClinicalTrials.Gov ID:

NCT1413240

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Muhammad M Iqbal
Phone: 315-464-1814
Email: iqbalmuh@upstate.edu

Return to Previous Page || Search Again

Top